Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure (NASDAQ:NVCR – Get Rating) and Alphatec (NASDAQ:ATEC – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, earnings, profitability and institutional ownership. Institutional & Insider Ownership 74.5% of NovoCure shares are owned by institutional […]
Gulf International Bank UK Ltd trimmed its stake in NovoCure Limited (NASDAQ:NVCR – Get Rating) by 19.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,842 shares of the medical equipment provider’s stock after selling 4,000 shares during the quarter. […]
NovoCure stock is way down and attracting bargain shoppers.
Quarterly net revenues of $133.6 million with 77% gross margin Last patient enrolled in phase 3 pivotal INNOVATE-3 trial for recurrent ovarian cancer Novocure (NASDAQ: NVCR) today reported financial
Novocure Reports First Quarter 2021 Financial Results and Provides Company Update Quarterly net revenues of $134.7 million with 80% gross margin Interim analysis for phase 3 pivotal LUNAR trial in non-small cell lung cancer concluded with favorable recommendation to continue the trial with reduced sample size Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended March 31, 2021, highlighting continued commercial strength despite changes in patterns of care in some regions driven by COVID-19, as well as continued progress across the company's clinical and product develo...